Legend Biotech (LEGN) Amortizatization of Intangibles (2020 - 2025)

Legend Biotech has reported Amortizatization of Intangibles for 6 years, with the latest figure at $10.0 million in Q3 2025.

• For the quarter ending Q3 2025, Amortizatization of Intangibles rose 72.56% year-over-year to $10.0 million; the trailing twelve-month figure through Sep 2025 stood at $5.1 million (down 32.09% YoY), and the FY2024 full-year result was $1.9 million, changed 0.36% from the prior year.
• Amortizatization of Intangibles for Q3 2025 stood at $10.0 million, up from $100000.0 in the prior quarter.
• The five-year high for Amortizatization of Intangibles was $10.0 million in Q3 2025, with the low at -$5.1 million in Q4 2024.
• Historically, Amortizatization of Intangibles has averaged $943631.6 across 5 years, with a median of $482000.0 in 2023.
• Annual changes were most pronounced in 2021 — Amortizatization of Intangibles soared 1451.85% — and 2024, when it slumped 1160.17%.
• Legend Biotech's Amortizatization of Intangibles stood at $419000.0 in 2021, then soared by 104.06% to $855000.0 in 2022, then plunged by 43.63% to $482000.0 in 2023, then tumbled by 1160.17% to -$5.1 million in 2024, then surged by 295.52% to $10.0 million in 2025.
• The last three Amortizatization of Intangibles figures came in at $10.0 million (Q3 2025), $100000.0 (Q2 2025), and $128000.0 (Q1 2025), per Business Quant data.